Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 4, 2017
Synthesis of relaxin-2 and insulin-like peptide 5 enabled by novel tethering and traceless chemical excisionKishore Thalluri, Binbin Kou, Xu Yang, et al.
ACS Chemical Biology|July 26, 2019
A Disulfide Scan of Insulin by [3 + 1] Methodology Exhibits Site-Specific Influence on BioactivityFlorence M Brunel, John P Mayer, Vasily M Gelfanov, et al.
Journal of Medicinal Chemistry|May 15, 2020
Addition of Sialic Acid to Insulin Confers Superior Physical Properties and BioequivalenceDaniel E K Kabotso, David Smiley, John P Mayer, et al.
Journal of Medicinal Chemistry|April 6, 2021
Optimization of Truncated Glucagon Peptides to Achieve Selective, High Potency, Full AntagonistsBin Yang, Vasily M Gelfanov, Diego Perez-Tilve, et al.
Nature Reviews. Drug Discovery|November 24, 2021
Anti-obesity drug discovery: advances and challengesTimo D Müller, Matthias Blüher, Matthias H Tschöp, et al.
Organic Letters|June 7, 2018
High-Yield Synthesis of Human Insulin-Like Peptide 5 Employing a Nonconventional StrategyAlexander N Zaykov, Vasily M Gelfanov, Fa Liu, et al.
Chemmedchem|February 22, 2018
Synthesis and Characterization of the R27S Genetic Variant of Insulin-like Peptide 5Alexander N Zaykov, Vasily M Gelfanov, Fa Liu, et al.
Protein and Peptide Letters|February 22, 2008
Crystallization and preliminary x-ray analysis of anti-obesity peptide hormone oxyntomodulinPengyun Li, Tanya Rogers, David Smiley, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 11, 2007
Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agentPengyun Li, Tanya Rogers, David Smiley, et al.
Pageof 14